title: Prothrombotic abnormalities in childhood ischaemic stroke.
abstract: Childhood ischaemic stroke, incorporating arterial ischaemic stroke and cerebral sinus venous thrombosis, is associated with significant morbidity and mortality in children. The majority of cases in children present with well-recognised risk factors. The appreciation of the role prothrombotic abnormalities have in disease states is developing rapidly. Prothrombotic abnormalities are abnormalities of the coagulation system, fibrinolytic system, endothelial cells or platelets that lead to a reduced threshold for pathological thrombus formation. Our understanding of the role of prothrombotic abnormalities in childhood ischaemic stroke is increasing and has a direct bearing on the development of effective management and prevention strategies. We provide a brief background of prothrombotic abnormalities and review the available literature on prothrombotic markers in childhood ischaemic stroke. Overall, prothrombotic abnormalities have been identified in 20-50% of children presenting with AIS and 33-99% of children with cerebral sinus venous thrombosis. There appear to be a number of associations emerging including an increased frequency of factor V Leiden mutation, elevated lipoprotein (a), protein C deficiency and antiphospholipid antibodies in children presenting with arterial ischaemic stroke. The pathogenic role of prothrombotic abnormalities as predisposing to initial and recurrent childhood ischaemic stroke is becoming increasingly evident. The impact on treatment, however, will only be clarified with carefully designed, multi-institutional prospective studies.
authors.affiliation: Department of Haematology, Royal Children's Hospital, Melbourne, Australia.
authors.forename: Chris
authors.initials: C
authors.lastname: Barnes
authors.forename: Gabrielle
authors.initials: G
authors.lastname: Deveber
mesh_terms: D015415:Biomarkers / Q000097:blood; D002545:Brain Ischemia; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D012008:Recurrence; D020521:Stroke / Q000453:epidemiology / Q000209:etiology*; D019851:Thrombophilia / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology
chemical_list: D015415:Biomarkers